How acceptable is rapid whole genome sequencing for infectious disease management in hospitals? Perspectives of those involved in managing nosocomial SARS-CoV-2
View ORCID ProfilePaul Flowers, View ORCID ProfileJulie McLeod, View ORCID ProfileFiona Mapp, View ORCID ProfileOliver Stirrup, View ORCID ProfileJames Blackstone, View ORCID ProfileLuke B Snell, Christine Peters, View ORCID ProfileEmma Thomson, View ORCID ProfileAlison Holmes, View ORCID ProfileJames Price, View ORCID ProfileDave Partridge, View ORCID ProfileLaura Shallcross, View ORCID ProfileThushan I de Silva, View ORCID ProfileJudith Breuer
doi: https://doi.org/10.1101/2022.06.15.22276423
Paul Flowers
1School of Psychological Sciences and Health, University of Strathclyde
Julie McLeod
1School of Psychological Sciences and Health, University of Strathclyde
Fiona Mapp
3Institute for Global Health, UCL, London, UK
Oliver Stirrup
3Institute for Global Health, UCL, London, UK
James Blackstone
5Comprehensive Clinical Trials Unit, UCL, London, UK
Luke B Snell
6Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, UK
Christine Peters
7NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
Emma Thomson
8MRC Centre for Virus Research, UK
Alison Holmes
9Imperial College Healthcare NHS Trust, London, UK
James Price
9Imperial College Healthcare NHS Trust, London, UK
Dave Partridge
11Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Laura Shallcross
12Institute of Health Informatics, Faculty of Pop Health Sciences
Thushan I de Silva
13Department of Infection, Immunity and Cardiovascular Disease, Medical School, The University of Sheffield, Sheffield, UK
Judith Breuer
14Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, UCL, London, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data is not available given it is qualitative and anonymity of participants must be protected
Posted June 16, 2022.
How acceptable is rapid whole genome sequencing for infectious disease management in hospitals? Perspectives of those involved in managing nosocomial SARS-CoV-2
Paul Flowers, Julie McLeod, Fiona Mapp, Oliver Stirrup, James Blackstone, Luke B Snell, Christine Peters, Emma Thomson, Alison Holmes, James Price, Dave Partridge, Laura Shallcross, Thushan I de Silva, Judith Breuer
medRxiv 2022.06.15.22276423; doi: https://doi.org/10.1101/2022.06.15.22276423
How acceptable is rapid whole genome sequencing for infectious disease management in hospitals? Perspectives of those involved in managing nosocomial SARS-CoV-2
Paul Flowers, Julie McLeod, Fiona Mapp, Oliver Stirrup, James Blackstone, Luke B Snell, Christine Peters, Emma Thomson, Alison Holmes, James Price, Dave Partridge, Laura Shallcross, Thushan I de Silva, Judith Breuer
medRxiv 2022.06.15.22276423; doi: https://doi.org/10.1101/2022.06.15.22276423
Subject Area
Subject Areas
- Addiction Medicine (344)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2635)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12205)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4079)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2638)
- Health Policy (1000)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3856)
- Nursing (209)
- Nutrition (573)
- Oncology (2015)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (449)
- Public and Global Health (6509)
- Radiology and Imaging (1395)
- Respiratory Medicine (871)
- Rheumatology (402)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)